June 23rd marks Dravet Syndrome Awareness Day, focusing on this rare form of epilepsy that causes frequent seizures from an early age, often accompanied by delayed psychological development and behavioral disorders.

Families say the groundbreaking medicine is transforming the lives of children with Dravet syndrome.

A British study explores a new drug that goes to the root of this condition, which affects more than a hundred Portuguese people, instead of focusing on symptoms like current market options.

Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndrome Scientists have hailed a potentially life-changing drug for children with a hard to treat…

The first gene-regulating treatment for epilepsy achieves promising results in an initial trial with 81 patients